<p>Raji, REH and CD52-NS0 cells were assessed by flow cytometry for CD52 expression and high CD52 expressing (<sup>++</sup>) clones were identified for the three cell lines. Cells (either parent or <sup>++</sup> lines) were stained with irrelevant human IgG (a) or with alemtuzumab (b) and (c).</p
The aim of our study was to evaluate CD52 as a target molecule for antibody therapy for multiple mye...
<p>NB cells were stained with 1.0 µg ch14.18/CHO and 0.05 µg anti-CD56-APC, followed by incubation w...
<div><p>"Double-hit" and "double-expressor" lymphomas represent distinct but overlapping subsets of ...
<p>Antibodies were characterised by: (a) Direct binding of antibodies to HUT78 cells using flow cyto...
Alemtuzumab is a monoclonal antibody that targets cell surface CD52 and is effective in depleting ly...
Alemtuzumab is a monoclonal antibody that targets cell surface CD52 and is effective in depleting ly...
<div><p>Alemtuzumab is a monoclonal antibody that targets cell surface CD52 and is effective in depl...
<p>Selected humanized antibodies were characterised by: (a) Direct binding of antibodies to REH<sup>...
<p>Selected hybridoma supernatants or media spiked with irrelevant mouse IgG were assessed for bindi...
<p>Representative histograms of CD52 expression levels on each of the lymphoid (A) and myeloid (B) c...
Few reports on the successful treatment of T-cell large granular lymphocyte (LGL) leukemia with the ...
Multiple myeloma (MM) and primary sys-temic amyloidosis (AL) remain incurable disorders, and new tre...
Few reports on the successful treatment of T-cell large granular lymphocyte (LGL) leukemia with the...
Peripheral T-cell lymphoma unspecified (PTCL/U) is a rare tumor characterized by poor treatment resp...
Anti-CD52 therapy has been shown to be effective in the treatment of a number of B cell malignancies...
The aim of our study was to evaluate CD52 as a target molecule for antibody therapy for multiple mye...
<p>NB cells were stained with 1.0 µg ch14.18/CHO and 0.05 µg anti-CD56-APC, followed by incubation w...
<div><p>"Double-hit" and "double-expressor" lymphomas represent distinct but overlapping subsets of ...
<p>Antibodies were characterised by: (a) Direct binding of antibodies to HUT78 cells using flow cyto...
Alemtuzumab is a monoclonal antibody that targets cell surface CD52 and is effective in depleting ly...
Alemtuzumab is a monoclonal antibody that targets cell surface CD52 and is effective in depleting ly...
<div><p>Alemtuzumab is a monoclonal antibody that targets cell surface CD52 and is effective in depl...
<p>Selected humanized antibodies were characterised by: (a) Direct binding of antibodies to REH<sup>...
<p>Selected hybridoma supernatants or media spiked with irrelevant mouse IgG were assessed for bindi...
<p>Representative histograms of CD52 expression levels on each of the lymphoid (A) and myeloid (B) c...
Few reports on the successful treatment of T-cell large granular lymphocyte (LGL) leukemia with the ...
Multiple myeloma (MM) and primary sys-temic amyloidosis (AL) remain incurable disorders, and new tre...
Few reports on the successful treatment of T-cell large granular lymphocyte (LGL) leukemia with the...
Peripheral T-cell lymphoma unspecified (PTCL/U) is a rare tumor characterized by poor treatment resp...
Anti-CD52 therapy has been shown to be effective in the treatment of a number of B cell malignancies...
The aim of our study was to evaluate CD52 as a target molecule for antibody therapy for multiple mye...
<p>NB cells were stained with 1.0 µg ch14.18/CHO and 0.05 µg anti-CD56-APC, followed by incubation w...
<div><p>"Double-hit" and "double-expressor" lymphomas represent distinct but overlapping subsets of ...
DOI
Add to ORKG